Shoulder Innovations, Inc. (SI) is a publicly traded Financial Services sector company. As of May 21, 2026, SI trades at $13.73 with a market cap of $306.51M and a P/E ratio of 3.84. SI moved -0.37% today. Year to date, SI is +3.55%; over the trailing twelve months it is flat. Its 52-week range spans $10.92 to $17.94. Analyst consensus is strong buy with an average price target of $21.50. Rallies surfaces SI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Shoulder Innovations Launches InSet I-135RFX Stem with FDA Fracture Clearance: Shoulder Innovations launched the InSet I-135RFX Humeral Stem commercially after securing FDA 510(k) clearance for expanded fracture indications, enabling its use in primary, revision and fracture shoulder arthroplasty procedures. This third I-Series product, following the InSet 95 and 70, broadens the company’s implant portfolio and sales potential.
| Metric | Value |
|---|---|
| Price | $13.73 |
| Market Cap | $306.51M |
| P/E Ratio | 3.84 |
| EPS | $3.87 |
| Dividend Yield | 0.00% |
| 52-Week High | $17.94 |
| 52-Week Low | $10.92 |
| Volume | 100 |
| Avg Volume | 0 |
| Revenue (TTM) | $251.67M |
| Net Income | $130.71M |
| Gross Margin | 0.00% |
4 analysts cover SI: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.50.